Table 1.

Comparison of demographic and cancer parameters of patients with EBV-positive versus EBV-negative classical Hodgkin lymphoma. The statistical tests used are stated as footnote

	EBV-positive cHL	EBV-negative cHL
	(n=10)	(n=26)	P value
Age (years)	48; 24; 76	35; 19; 74	0.04 a
Male sex (n; %)	8; 80	10; 38.4	0.02 b
Nodular sclerosis HL (n; %)	7; 70	23; 88	0.18 b
Ann Arbor stage ≥ III (n; %)	5; 50	12; 46	0.83 b
Lymphocyte count (G/l)	1.27; 0.90; 1.70	1.26; 0.40; 3.30	0.96 a
Plasma EBV DNA (copies/ml)	3414; 0; 11,743	26; 0; 143	0.0002 a
EBV-seropositive (n; %)	10; 100	25; 96	0.52

^aunpaired t test (mean; min; max)

^bchi-square test